Dermatomyositis laboratory findings

Jump to navigation Jump to search

Dermatomyositis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Dermatomyositis from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dermatomyositis laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dermatomyositis laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dermatomyositis laboratory findings

CDC on Dermatomyositis laboratory findings

Dermatomyositis laboratory findings in the news

Blogs on Dermatomyositis laboratory findings

Directions to Hospitals Treating Dermatomyositis

Risk calculators and risk factors for Dermatomyositis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Creatine kinase (CK) and aldolase levels may be increased, which would be indicative of muscle damage.

Laboratory Findings

Blood tests such as creatine kinase (CK) and aldolase may help diagnose dematomyositis. Patients with dematomyositis may show increased CK and aldolase levels, indicating muscle damage.

References

Template:WH Template:WS